SILO PHARMA, INC. Interest Rate Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net
SILO PHARMA, INC. (SILO) had Interest Rate Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net of $85.73 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments
us-gaap:InterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet · last filed 2022-11-10
- 2022-09-30: Interest Rate Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $85.73K.
- 2022-06-30: Interest Rate Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $85.73K.
- 2022-03-31: Interest Rate Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net $85.73K.
| Period end | Interest Rate Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net |
|---|---|
| 2022-09-30 | $85.73K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $85.73K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $85.73K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |